Literature DB >> 23598837

Neurofibromatosis: types 1 and 2.

S Borofsky1, L M Levy.   

Abstract

Neurofibromatosis types 1 and 2 are a group of neurocutaneous syndromes resulting from disorders in cell regulation. Despite sharing a common name, neurofibromatosis types 1 and 2 are quite distinct phakomatoses, both clinically and genetically.

Entities:  

Mesh:

Year:  2013        PMID: 23598837      PMCID: PMC7965224          DOI: 10.3174/ajnr.A3534

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  12 in total

1.  Automated detection and volume measurement of plexiform neurofibromas in neurofibromatosis 1 using magnetic resonance imaging.

Authors:  Jeffrey Solomon; Katherine Warren; Eva Dombi; Nicholas Patronas; Brigitte Widemann
Journal:  Comput Med Imaging Graph       Date:  2004-07       Impact factor: 4.790

Review 2.  Neuro-ophthalmic features of the neurocutaneous syndromes.

Authors:  Jane W Chan
Journal:  Int Ophthalmol Clin       Date:  2012

Review 3.  Neurofibromatosis type 2.

Authors:  Ashok R Asthagiri; Dilys M Parry; John A Butman; H Jeffrey Kim; Ekaterini T Tsilou; Zhengping Zhuang; Russell R Lonser
Journal:  Lancet       Date:  2009-05-22       Impact factor: 79.321

Review 4.  Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis.

Authors:  Sebastian Laycock-van Spyk; Nick Thomas; David N Cooper; Meena Upadhyaya
Journal:  Hum Genomics       Date:  2011-10       Impact factor: 4.639

5.  Brainstem lesions in neurofibromatosis type 1.

Authors:  Nicole J Ullrich; Ali I Raja; Mira B Irons; Mark W Kieran; Liliana Goumnerova
Journal:  Neurosurgery       Date:  2007-10       Impact factor: 4.654

6.  Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis.

Authors:  E Legius; D A Marchuk; F S Collins; T W Glover
Journal:  Nat Genet       Date:  1993-02       Impact factor: 38.330

7.  Whole body MR imaging in neurofibromatosis type 1.

Authors:  S F L Van Meerbeeck; K L Verstraete; S Janssens; G Mortier
Journal:  Eur J Radiol       Date:  2008-12-16       Impact factor: 3.528

Review 8.  Magic but treatable? Tumours due to loss of merlin.

Authors:  C O Hanemann
Journal:  Brain       Date:  2007-10-16       Impact factor: 13.501

Review 9.  Clinical and genetic aspects of neurofibromatosis 1.

Authors:  Kimberly Jett; Jan M Friedman
Journal:  Genet Med       Date:  2010-01       Impact factor: 8.822

Review 10.  Nf2/Merlin: a coordinator of receptor signalling and intercellular contact.

Authors:  M Curto; A I McClatchey
Journal:  Br J Cancer       Date:  2007-10-30       Impact factor: 7.640

View more
  2 in total

Review 1.  Diagnosis and differential diagnosis of large-vessel vasculitides.

Authors:  Gokhan Keser; Kenan Aksu
Journal:  Rheumatol Int       Date:  2018-09-17       Impact factor: 2.631

2.  Oculomotor nerve palsy in neurofibromatosis type 2.

Authors:  Aymen Shahab; Hafsa Sardar; Samaa Akhtar; Anam Safdar; Muhammad Ismail Safi; Izaz Ahmad; Faheemullah Khan
Journal:  Radiol Case Rep       Date:  2022-09-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.